Non-Carbapenem Antibiotics to Treat Severe Extended-Spectrum-β- Lactamase-Producing Enterobacteriaceae Infections in Intensive Care Unit Patients - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue International Journal of Antimicrobial Agents Année : 2019

Non-Carbapenem Antibiotics to Treat Severe Extended-Spectrum-β- Lactamase-Producing Enterobacteriaceae Infections in Intensive Care Unit Patients

Helga Junot

Résumé

OBJECTIVES: The aim of this study was to evaluate the use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) infections in intensive care unit (ICU) patients. METHODS: This retrospective observational study conducted in two ICUs compared the outcomes of patients with ESBL-E infections administered a carbapenem or a non-carbapenem antibiotic as their definitive treatment. The primary outcome was treatment failure within 30 days, a composite endpoint of ESBL-E infection recurrence and 30-day mortality. Secondary outcomes included 30-day and in-hospital mortality rates, ESBL-E infection recurrence and infection(s) due to other pathogen(s). RESULTS: Among 107 patients included in the study, 67 received a carbapenem and 40 received a non-carbapenem antibiotic as their definitive treatment. Clinical characteristics of the two groups were similar. Comparing patients given a non-carbapenem antibiotic with those administered a carbapenem, they had similar 30-day treatment failure (43% vs. 61%, respectively; P = 0.06) and ESBL-E infection recurrence rates (25% vs. 22%; P = 0.8), but the former had lower 30-day mortality (23% vs. 45%; P = 0.02) and in-hospital mortality rates (23% vs. 49%; P = 0.005). Secondary infection rates caused by other pathogen(s), including Clostridium difficile, were comparable. Outcomes were comparable regardless of whether or not patients received an empirical carbapenem. CONCLUSION: For ICU patients with severe ESBL-E infections, treatment with a non-carbapenem antibiotic was not associated with poorer outcomes compared with a carbapenem antibiotic.
Fichier principal
Vignette du fichier
Luyt et al. - 2019 - Non-Carbapenem Antibiotics to Treat Severe Extende.pdf (592.71 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02272285 , version 1 (27-08-2019)

Identifiants

Citer

Charles-Edouard Luyt, Morgane Faure, Isabelle Bonnet, Sébastien Besset, Florent Huang, et al.. Non-Carbapenem Antibiotics to Treat Severe Extended-Spectrum-β- Lactamase-Producing Enterobacteriaceae Infections in Intensive Care Unit Patients. International Journal of Antimicrobial Agents, 2019, 53 (5), pp.547-552. ⟨10.1016/j.ijantimicag.2019.02.001⟩. ⟨hal-02272285⟩
43 Consultations
165 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More